Autori: Secen Nevena
| Naslov | Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA) (Article) |
| Autori | Passiglia Francesco ... Secen Nevena ... (broj koautora 36) |
| Info | JOURNAL OF THORACIC ONCOLOGY, (2025), vol. 20 br. 5, str. 614-624 |
| Projekat | AstraZeneca; Amgen; BeiGene; Blueprint Medicines; Boeringher Ingelheim; Gilead; Incyte; Eli Lilly; Merck; MSD; Novartis; Pfizer; Roche; Sanofi; Thermo Fisher Scientific |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
